Published in J Immunol on May 15, 1991
Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest (1996) 2.92
Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest (1997) 1.86
Role of beta 1 and beta 2 integrins in the adhesion of human CD34hi stem cells to bone marrow stroma. J Clin Invest (1992) 1.65
Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. J Clin Invest (1994) 1.58
A monoclonal antibody recognizing very late activation antigen-4 inhibits eosinophil accumulation in vivo. J Exp Med (1993) 1.53
Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation. J Exp Med (1996) 1.33
CD18-independent neutrophil and mononuclear leukocyte emigration into the peritoneum of rabbits. J Clin Invest (1993) 1.30
Adhesion to fibronectin prolongs eosinophil survival. J Exp Med (1993) 1.25
Bronchial biopsy evidence for leukocyte infiltration and upregulation of leukocyte-endothelial cell adhesion molecules 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest (1994) 1.22
Eosinophil adhesion to nasal polyp endothelium is P-selectin-dependent. J Exp Med (1994) 1.17
Eosinophils in the 1990s: new perspectives on their role in health and disease. Postgrad Med J (1994) 1.11
Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol (2014) 1.08
Antibody to VLA-4, but not to L-selectin, protects neuronal M2 muscarinic receptors in antigen-challenged guinea pig airways. J Clin Invest (1997) 1.04
Characterization of adhesive interactions between human endothelial cells and megakaryocytes. J Clin Invest (1993) 0.98
Mediator and cytokine mechanisms in asthma. Thorax (1993) 0.97
Human endothelial cells regulate survival and proliferation of human mast cells. J Exp Med (2000) 0.97
Integrin alpha 4 beta 7 mediates human eosinophil interaction with MAdCAM-1, VCAM-1 and fibronectin. Immunology (1996) 0.95
Adhesion to fibronectin primes eosinophils via alpha 4 beta 1 (VLA-4). Immunology (1994) 0.93
Lung eosinophilia is dependent on IL-5 and the adhesion molecules CD18 and VLA-4, in a guinea-pig model. Immunology (1995) 0.92
Recent advances in asthma. Postgrad Med J (1992) 0.92
Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin. Br J Pharmacol (1994) 0.92
Adhesion molecules in vernal keratoconjunctivitis. Br J Ophthalmol (1997) 0.91
Pulmonary neuronal M2 muscarinic receptor function in asthma and animal models of hyperreactivity. Thorax (1998) 0.91
Chemokines in the limbal form of vernal keratoconjunctivitis. Br J Ophthalmol (2000) 0.90
Strain-Related Differences in the Immune Response: Relevance to Human Stroke. Transl Stroke Res (2016) 0.89
Integrin activation States and eosinophil recruitment in asthma. Front Pharmacol (2013) 0.89
Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. J Clin Invest (1993) 0.87
The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. J Clin Invest (1998) 0.86
Mycobacterial infection inhibits established allergic inflammatory responses via alteration of cytokine production and vascular cell adhesion molecule-1 expression. Immunology (2002) 0.86
Intercellular adhesion molecule-1 on eosinophils is involved in eosinophil protein X release induced by cytokines. Immunology (1997) 0.83
Regulated expression of vascular cell adhesion molecule-1 in human malignant melanoma. Am J Pathol (1992) 0.80
The impact of eotaxin- and IL-5-induced adhesion and transmigration on eosinophil activity markers. Inflammation (2000) 0.79
Allergen-stimulated T lymphocytes from allergic patients induce vascular cell adhesion molecule-1 (VCAM-1) expression and IL-6 production by endothelial cells. Clin Exp Immunol (1995) 0.79
VCAM-1 and eosinophilia in diffuse sino-nasal polyps. Eur Arch Otorhinolaryngol (2008) 0.79
Role of inflammation in nocturnal asthma. Thorax (1994) 0.78
The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells. Br J Pharmacol (2001) 0.77
Fc gamma RI and Fc gamma RIII on polymorphonuclear leucocytes in cord blood. Arch Dis Child Fetal Neonatal Ed (1994) 0.77
Eosinophil-expressed galectin-3 regulates cell trafficking and migration. Front Pharmacol (2013) 0.77
Effects of monoclonal antibodies to adhesion molecules on eosinophilic myocarditis in Toxocara canis-infected CBA/J mice. Clin Exp Immunol (1998) 0.76
Interleukin 4 increases human synovial cell expression of VCAM-1 and T cell binding. Ann Rheum Dis (1994) 0.75
Isolation and functional characterization of T cells from human sputum. Clin Exp Immunol (1995) 0.75
Implicating adhesion molecules in nasal allergic inflammation. Eur Arch Otorhinolaryngol (1995) 0.75
Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med (1992) 11.90
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature (1983) 5.20
Inhibition of Bax channel-forming activity by Bcl-2. Science (1997) 5.10
A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med (1972) 3.93
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest (1991) 3.88
Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med (1999) 3.84
Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis (1990) 3.70
Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2000) 3.63
The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol (1971) 3.51
Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell (1987) 3.46
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45
Non-eosinophilic corticosteroid unresponsive asthma. Lancet (1999) 3.25
Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes. Clin Exp Immunol (1970) 3.09
Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis (1989) 3.06
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol (1991) 2.88
Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J (2007) 2.78
An eosinophil leukocyte chemotactic factor of anaphylaxis. J Exp Med (1971) 2.65
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids. Thorax (2002) 2.63
CCR7 expression and memory T cell diversity in humans. J Immunol (2001) 2.42
Effect of T-cell peptides derived from Fel d 1 on allergic reactions and cytokine production in patients sensitive to cats: a randomised controlled trial. Lancet (2002) 2.38
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ (1991) 2.32
T cells and eosinophils in the pathogenesis of asthma. Immunol Today (1992) 2.30
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol (1997) 2.28
Hemopoietic responses in mice injected with purified recombinant murine GM-CSF. Exp Hematol (1987) 2.25
CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis (1990) 2.18
Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions. Clin Allergy (1985) 2.15
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. Clin Exp Immunol (1970) 2.13
Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol (1993) 2.11
Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet (1992) 2.06
Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol (1994) 2.05
Leucoattractants enhance complement receptors on human phagocytic cells. Clin Exp Immunol (1979) 2.04
The relationship between infiltrating CD4+ lymphocytes, activated eosinophils, and the magnitude of the allergen-induced late phase cutaneous reaction in man. J Immunol (1988) 2.00
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med (1996) 1.93
Expression and generation of interleukin-8, IL-6 and granulocyte-macrophage colony-stimulating factor by bronchial epithelial cells and enhancement by IL-1 beta and tumour necrosis factor-alpha. Immunology (1992) 1.93
IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology (1990) 1.85
Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol (1982) 1.84
Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis (1991) 1.84
Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma. J Exp Med (1995) 1.83
Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis. Eur Respir J (2000) 1.81
T lymphocyte activation in acute severe asthma. Lancet (1988) 1.81
Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. J Clin Invest (1982) 1.77
Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax (2003) 1.75
Corticosteroid resistance in chronic asthma. Br Med J (Clin Res Ed) (1981) 1.75
Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms. Nucleic Acids Res (2000) 1.73
The identification of fibrinopeptide B as a chemotactic agent derived from human fibrinogen. Br J Haematol (1974) 1.70
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Eur J Immunol (1997) 1.69
Eosinophils 1992. Immunol Today (1992) 1.69
Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis (1992) 1.68
The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today (1999) 1.67
Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics. Am J Respir Cell Mol Biol (1993) 1.67
Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol (2001) 1.67
Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest (1993) 1.66
Double-blind, placebo-controlled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med (1996) 1.64
Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils. J Exp Med (1991) 1.64
Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol (1989) 1.63
Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia. J Immunol (1977) 1.63
Recombinant murine GM-CSF from E. coli has biological activity and is neutralized by a specific antiserum. EMBO J (1985) 1.62
Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression. Proc Natl Acad Sci U S A (1985) 1.62
New insights into the role of the mast cell in asthma. Clin Exp Allergy (2003) 1.61
Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol (1997) 1.59
Preferential messenger RNA expression of Th1-type cells (IFN-gamma+, IL-2+) in classical delayed-type (tuberculin) hypersensitivity reactions in human skin. J Immunol (1992) 1.59
Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood (1992) 1.59
Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4. Br J Pharmacol (1983) 1.56
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils. J Immunol (1979) 1.53
Grass pollen immunotherapy decreases the number of mast cells in the skin. Clin Exp Allergy (1999) 1.53
The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clin Exp Allergy (2005) 1.52
Interaction between isoprenaline and aminophylline in asthma. Thorax (1977) 1.52
Expression of CCR8 is increased in asthma. Clin Exp Allergy (2010) 1.51
Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. N Engl J Med (1982) 1.51
Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature (1985) 1.51
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med (1996) 1.50
Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J Exp Med (1999) 1.48
Mediators of immediate-type hypersensitivity in sputum from patients with chronic bronchitis and asthma. Lancet (1977) 1.45
In vitro actions on hemopoietic cells of recombinant murine GM-CSF purified after production in Escherichia coli: comparison with purified native GM-CSF. J Cell Physiol (1986) 1.44
The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature (1977) 1.43
CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5. Effect of glucocorticoid therapy. Am Rev Respir Dis (1993) 1.43
Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol (1995) 1.42
Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol (1995) 1.42
Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax (1993) 1.41
T lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am Rev Respir Dis (1992) 1.41
Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med (1997) 1.39